Ovarian hyperstimulation syndrome

Changed by Joshua Yap, 6 Jan 2023
Disclosures - updated 15 Jul 2022: Nothing to disclose

Updates to Article Attributes

Body was changed:

Ovarian hyperstimulation syndrome (OHSS) is a complication of controlled ovarian stimulation, which is an assisted reproduction technique used for in vitro fertilisation (IVF). Rarely, it may also occur spontaneously in pregnancy (see below). It consists of ovarian enlargement with thean extravascular accumulation of fluid leading to variable weight gain, ascitespleural effusion, intravascular volume depletion, and oliguria.

Epidemiology

The syndrome is relatively common, occurring in ~5% of patients undergoing in vitro fertilisation (IVF). There is probably an even higher incidence of the syndrome in "egg donors" due to their young age (which is a known risk factor for the disease), however, there is a known problem of lack of reporting of such cases.

Risk factors
  • high baseline ovarian volume 8

  • background polycystic ovaries 9

  • low body weight 8

  • long ovulation induction cycle duration 8

Clinical presentation

The clinical picture may vary from abdominal distension and discomfort to potentially life-threatening capillary leak with fluid sequestration in a third space, and massive ovarian enlargement. Pain, abdominal distention, nausea, and vomiting are frequently seen as symptoms 18.

Pathology

Controlled ovarian stimulation is an assisted reproductive technique used to increase oocyte (egg) retrieval success and can cause ovarian hyperstimulation syndrome 18.

Aetiology

This syndrome is characterised by massive cystic ovarian enlargement and fluid shift from the intravascular compartment into the peritoneal, pleural or pericardial spaces. The vascular fluid leakage is thought to result from an increased capillary permeability of mesothelial surfaces under the action of one or several vasoactive ovarian factors produced by multiple corpora lutea. Acute pelvic pain may result from stretching of the ovarian capsule or haemorrhage/rupture of a follicle.

Markers
  • serum oestradiol (E2) levels are elevated 18
Subtypes

Spontaneous ovarian hyperstimulation

This

syndrome is a rare subtype and occurs in the absence of any external stimulation. This form can occur in pregnancy 15.

There are also very rare sporadic forms that carry, or due to a genetic component. These have an association with early pubertal development and primary hypothyroidism (Van Wyk-Grumbach syndrome).

Ovarian stimulation in the hypothyroid child may result in oestrogen production, breast development, endometrial proliferation, and vaginal bleeding. It is likely that raised TSH concentrations bind and stimulate the FSH receptor, although a similar overlap phenomenon might occur at the level of the pituitary, with enhanced TRH production stimulating the GnRH receptor with subsequent ovarian enlargement. The cystic ovarian enlargement resolves with thyroid hormone replacement. A hyperstimulation phenomenon in patients with an abnormal FSH receptor has been described.

Classification

BasedThe modified Golan classification subdivides ovarian hyperstimulation syndrome based on the clinical presentation and imaging findings, the modified Golan classification subdivides OHSS 12,17.

Markers
  • serum oestradiol (E2) levels are elevated 18

Radiographic features

Imaging findings tend to be similar on ultrasound, CT and MRI.

Ultrasound

Treatment and prognosis

The syndrome is usually self-limiting in most cases and management is mainly supportive, however, cases with fatal outcomes have been reported 14. Severe cases usually require hospitalisation and close monitoring of haematocrit, liver function, renal function, serum electrolytes and oxygen saturation.

The profoundly altered maternal environment of OHSSovarian hyperstimulation syndrome is a significant risk factor for miscarriage, especially when occurring in the early phase after IVF (defined as <10 days after oocyte retrieval) 16.

Complications

Differential diagnosis

For ultrasound appearances in mild cases consider

Practical points

Familiarity with ovarian hyperstimulation syndrome and the appropriate clinical setting should help avoid the incorrect diagnosis of an ovarian cystic neoplasm. When encountering severe forms not suspected by the clinician suggesting the diagnosis may reduce both morbidity and mortality.

  • -<p><strong>Ovarian hyperstimulation syndrome (OHSS)</strong> is a complication of controlled ovarian stimulation, which is an assisted reproduction technique used for in vitro fertilisation (IVF). Rarely, it may also occur spontaneously in pregnancy (see below). It consists of ovarian enlargement with the extravascular accumulation of fluid leading to variable weight gain, <a href="/articles/ascites">ascites</a>, <a href="/articles/pleural-effusion">pleural effusion</a>, intravascular volume depletion, and oliguria.</p><h4>Epidemiology</h4><p>The <a href="/articles/syndrome">syndrome</a> is relatively common, occurring in ~5% of patients undergoing in vitro fertilisation (IVF). There is probably an even higher incidence of the syndrome in "egg donors" due to their young age (which is a known risk factor for the disease) however there is a known problem of lack of reporting of such cases.</p><h5>Risk factors</h5><ul>
  • -<li>high baseline ovarian volume <sup>8</sup>
  • -</li>
  • -<li>background <a href="/articles/polycystic-ovaries">polycystic ovaries</a> <sup>9</sup>
  • -</li>
  • -<li>low body weight <sup>8</sup>
  • -</li>
  • -<li>long ovulation induction cycle duration <sup>8</sup>
  • -</li>
  • -</ul><h4>Clinical presentation</h4><p>The clinical picture may vary from abdominal distension and discomfort to potentially life-threatening capillary leak with fluid sequestration in a third space, and massive ovarian enlargement. Pain, abdominal distention, nausea, and vomiting are frequently seen as symptoms <sup>18</sup>.</p><h4>Pathology</h4><p>Controlled ovarian stimulation is an assisted reproductive technique used to increase oocyte (egg) retrieval success and can cause ovarian hyperstimulation syndrome <sup>18</sup>.</p><p>This syndrome is characterised by massive cystic ovarian enlargement and fluid shift from the intravascular compartment into the peritoneal, pleural or pericardial spaces. The vascular fluid leakage is thought to result from an increased capillary permeability of mesothelial surfaces under the action of one or several vasoactive ovarian factors produced by multiple <a href="/articles/corpus-luteum">corpora lutea</a>. Acute pelvic pain may result from stretching of the ovarian capsule or haemorrhage/rupture of a <a href="/articles/ovarian-follicle">follicle</a>.</p><h5>Markers</h5><ul><li>serum oestradiol (E<sub>2</sub>) levels are elevated <sup>18</sup>
  • -</li></ul><h5>Subtypes</h5><h6>Spontaneous ovarian hyperstimulation</h6><p>This subtype occurs in the absence of any external stimulation. This form can occur in pregnancy <sup>15</sup>.</p><p>There are also very rare sporadic forms that carry a genetic component. These have an association with early pubertal development and primary hypothyroidism (<a href="/articles/van-wyk-grumbach-syndrome">Van Wyk-Grumbach syndrome</a>). Ovarian stimulation in the <a href="/articles/hypothyroidism">hypothyroid</a> child may result in oestrogen production, breast development, endometrial proliferation, and vaginal bleeding. It is likely that raised TSH concentrations bind and stimulate the FSH receptor, although a similar overlap phenomenon might occur at the level of the pituitary, with enhanced TRH production stimulating the GnRH receptor with subsequent ovarian enlargement. The cystic ovarian enlargement resolves with thyroid hormone replacement. A hyperstimulation phenomenon in patients with an abnormal FSH receptor has been described.</p><h4>Classification</h4><p>Based on the clinical presentation and imaging findings, the <a href="/articles/modified-golan-classification-of-ovarian-hyperstimulation-syndrome">modified Golan classification</a> subdivides OHSS <sup>12,17</sup>.</p><h4>Radiographic features</h4><p>Imaging findings tend to be similar on ultrasound, CT and MRI.</p><h5>Ultrasound</h5><ul>
  • -<li>typically shows bilateral symmetric enlargement of ovaries (often &gt;12 cm in size)</li>
  • -<li>multiple cysts of varying sizes, giving the classic <a href="/articles/spoke-wheel-sign-ohss">spoke-wheel appearance</a>
  • -</li>
  • -<li>associated <a href="/articles/ascites">ascites</a> and <a href="/articles/pleural-effusion">pleural</a> +/- <a href="/articles/pericardial-effusion">pericardial effusion</a> (which is due to capillary leak) may also be present</li>
  • -</ul><h4>Treatment and prognosis</h4><p>The syndrome is usually <a href="/articles/self-limiting-2">self-limiting</a> in most cases and management is mainly supportive, however, cases with fatal outcomes have been reported <sup>14</sup>. Severe cases usually require hospitalisation and close monitoring of haematocrit, liver function, renal function, serum electrolytes and oxygen saturation.</p><p>The profoundly altered maternal environment of OHSS is a significant risk factor for <a href="/articles/miscarriage">miscarriage</a>, especially when occurring in the early phase after IVF (defined as &lt;10 days after oocyte retrieval) <sup>16</sup>.</p><h5>Complications</h5><ul>
  • +<p><strong>Ovarian hyperstimulation syndrome (OHSS)</strong> is a complication of controlled ovarian stimulation, which is an assisted reproduction technique used for in vitro fertilisation (IVF). Rarely, it may also occur spontaneously in pregnancy (see below). It consists of ovarian enlargement with an extravascular accumulation of fluid leading to variable weight gain, <a href="/articles/ascites">ascites</a>, <a href="/articles/pleural-effusion">pleural effusion</a>, intravascular volume depletion, and oliguria.</p><h4>Epidemiology</h4><p>The <a href="/articles/syndrome">syndrome</a> is relatively common, occurring in ~5% of patients undergoing in vitro fertilisation (IVF). There is probably an even higher incidence of the syndrome in "egg donors" due to their young age (which is a known risk factor for the disease), however, there is a known problem of lack of reporting of such cases.</p><h5>Risk factors</h5><ul>
  • +<li><p>high baseline ovarian volume <sup>8</sup></p></li>
  • +<li><p>background <a href="/articles/polycystic-ovaries">polycystic ovaries</a> <sup>9</sup></p></li>
  • +<li><p>low body weight <sup>8</sup></p></li>
  • +<li><p>long ovulation induction cycle duration <sup>8</sup></p></li>
  • +</ul><h4>Clinical presentation</h4><p>The clinical picture may vary from abdominal distension and discomfort to potentially life-threatening capillary leak with fluid sequestration in a third space, and massive ovarian enlargement. Pain, abdominal distention, nausea, and vomiting are frequently seen as symptoms <sup>18</sup>.</p><h4>Pathology</h4><p>Controlled ovarian stimulation is an assisted reproductive technique used to increase oocyte (egg) retrieval success and can cause ovarian hyperstimulation syndrome <sup>18</sup>.</p><h5>Aetiology</h5><p>This syndrome is characterised by massive cystic ovarian enlargement and fluid shift from the intravascular compartment into the peritoneal, pleural or pericardial spaces. The vascular fluid leakage is thought to result from increased capillary permeability of mesothelial surfaces under the action of one or several vasoactive ovarian factors produced by multiple <a href="/articles/corpus-luteum">corpora lutea</a>. Acute pelvic pain may result from stretching of the ovarian capsule or haemorrhage/rupture of a <a href="/articles/ovarian-follicle">follicle</a>.</p><p>Spontaneous ovarian hyperstimulation syndrome is a rare subtype and occurs in the absence of any external stimulation. This form can occur in pregnancy <sup>15</sup>, or due to a genetic component. These have an association with early pubertal development and primary hypothyroidism (<a href="/articles/van-wyk-grumbach-syndrome">Van Wyk-Grumbach syndrome</a>). </p><p>Ovarian stimulation in the <a href="/articles/hypothyroidism">hypothyroid</a> child may result in oestrogen production, breast development, endometrial proliferation, and vaginal bleeding. It is likely that raised TSH concentrations bind and stimulate the FSH receptor, although a similar overlap phenomenon might occur at the level of the pituitary, with enhanced TRH production stimulating the GnRH receptor with subsequent ovarian enlargement. The cystic ovarian enlargement resolves with thyroid hormone replacement. A hyperstimulation phenomenon in patients with an abnormal FSH receptor has been described.</p><h5>Classification</h5><p>The <a href="/articles/modified-golan-classification-of-ovarian-hyperstimulation-syndrome">modified Golan classification</a> subdivides ovarian hyperstimulation syndrome based on the clinical presentation and imaging findings <sup>12,17</sup>.</p><h5>Markers</h5><ul><li><p>serum oestradiol (E<sub>2</sub>) levels are elevated <sup>18</sup></p></li></ul><h4>Radiographic features</h4><p>Imaging findings tend to be similar on ultrasound, CT and MRI.</p><h5>Ultrasound</h5><ul>
  • +<li><p>typically shows bilateral symmetric enlargement of ovaries (often &gt;12 cm in size)</p></li>
  • +<li><p>multiple cysts of varying sizes, giving the classic <a href="/articles/spoke-wheel-sign-ohss">spoke-wheel appearance</a></p></li>
  • +<li><p>associated <a href="/articles/ascites">ascites</a> and <a href="/articles/pleural-effusion">pleural</a> +/- <a href="/articles/pericardial-effusion">pericardial effusion</a> (due to capillary leak) may also be present</p></li>
  • +</ul><h4>Treatment and prognosis</h4><p>The syndrome is usually <a href="/articles/self-limiting-2">self-limiting</a> in most cases and management is mainly supportive, however, cases with fatal outcomes have been reported <sup>14</sup>. Severe cases usually require hospitalisation and close monitoring of haematocrit, liver function, renal function, serum electrolytes and oxygen saturation.</p><p>The profoundly altered maternal environment of ovarian hyperstimulation syndrome is a significant risk factor for <a href="/articles/miscarriage">miscarriage</a>, especially when occurring in the early phase after IVF (defined as &lt;10 days after oocyte retrieval) <sup>16</sup>.</p><h5>Complications</h5><ul>
  • -<a href="/articles/hypo-volaemic-shock">hypovolaemic shock </a>with resultant<ul>
  • -<li><a href="/articles/thromboembolic-disease">thromboembolic disease</a></li>
  • -<li><a href="/articles/stroke">stroke</a></li>
  • +<p><a href="/articles/hypovolemic-shock" title="hypovolaemic shock">hypovolaemic shock</a> with resultant</p>
  • +<ul>
  • +<li><p><a href="/articles/thromboembolic-disease">thromboembolic disease</a></p></li>
  • +<li><p><a href="/articles/stroke">stroke</a></p></li>
  • -<li>increased risk of <a href="/articles/ovarian-torsion">ovarian torsion</a> <sup>6</sup>
  • -</li>
  • +<li><p>increased risk of <a href="/articles/ovarian-torsion">ovarian torsion</a> <sup>6</sup></p></li>
  • -<a href="/articles/polycystic-ovaries">polycystic ovaries </a><ul>
  • -<li>cysts are typically small</li>
  • -<li>no ascites or pleural effusions</li>
  • +<p><a href="/articles/polycystic-ovaries">polycystic ovaries</a></p>
  • +<ul>
  • +<li><p>cysts are typically small</p></li>
  • +<li><p>no ascites or pleural effusions</p></li>
  • -<li>
  • -<a href="/articles/theca-lutein-cyst">theca lutein cysts </a>associated with <a href="/articles/gestational-trophoblastic-disease">gestational trophoblastic disease</a>: some also considered a part of OHSS</li>
  • -<li><a href="/articles/ovarian-mucinous-tumours">mucinous ovarian malignancy </a></li>
  • +<li><p><a href="/articles/theca-lutein-cyst">theca lutein cysts </a>associated with <a href="/articles/gestational-trophoblastic-disease">gestational trophoblastic disease</a>: some also considered a part of ovarian hyperstimulation syndrome</p></li>
  • +<li><p><a href="/articles/ovarian-mucinous-tumours">mucinous ovarian malignancy</a></p></li>
Images Changes:

Image 4 Ultrasound ( update )

Caption was changed:
Case 4: grade 5 OHSS

Image 12 Ultrasound (right: axial and longitudinal) ( update )

Caption was changed:
Case 10: ultrasound

Image 13 MRI (Gradient echo fat saturation) ( update )

Caption was changed:
Case 10: MRI

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.